The Student News Site of Harvard-Westlake School

The Harvard-Westlake Chronicle

The Student News Site of Harvard-Westlake School

The Harvard-Westlake Chronicle

The Student News Site of Harvard-Westlake School

The Harvard-Westlake Chronicle

FDA approves booster vaccine dose for high risk populations

FDA approves booster vaccine dose for high risk populations

Natalie Cosgrove October 27, 2021

The Food and Drug Administration (FDA) approved the Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for those age 65 and above and for 18 to 64 year olds who are at high risk for contracting COVID-19. Visual...

Load More Stories